These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34068380)

  • 21. Retrospective, Observational Study to Determine the Choice of Antihypertensive agent According to Stage of Hypertension, Risk factors and Co-morbidities in Real World Setting in India: A Report of Baseline Data.
    Khan MY; Pandit S; Dalal J; Bansal S; Iyengar SS; Karnik R; Khanna U; Mane A; Mehta S; Shah S
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Demographic Characteristics of Patients with Coexistent Hypertension, Type 2 Diabetes Mellitus, and Dyslipidemia: A Retrospective Study from India.
    Dalal J; Chandra P; Chawla R; Kumar V; Abdullakutty J; Natarajan V; Naqvi SMH; Gaurav K; Rathod R; Dhanaki G; Kotak B; Shah S
    Drugs Real World Outcomes; 2024 Mar; 11(1):167-176. PubMed ID: 38038836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Roussel R; Lorraine J; Rodriguez A; Salaun-Martin C
    Adv Ther; 2015 Nov; 32(11):1029-64. PubMed ID: 26581749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database.
    Fried L; Schmedt N; Folkerts K; Bowrin K; Raad H; Batech M; Kovesdy C
    Nephrol Dial Transplant; 2023 Feb; 38(3):630-643. PubMed ID: 35389468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Jepson C; Hsu JY; Fischer MJ; Kusek JW; Lash JP; Ricardo AC; Schelling JR; Feldman HI;
    Am J Kidney Dis; 2019 Jan; 73(1):72-81. PubMed ID: 30177484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia.
    Comas J; Arcos E; Castell C; Cases A; Martínez-Castelao A; Doñate T; Esmatjes E
    Nephrol Dial Transplant; 2013 May; 28(5):1191-8. PubMed ID: 23147160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microalbuminuria as the Tip of Iceberg in Type 2 Diabetes Mellitus: Prevalence, Risk Factors, and Associated Diabetic Complications.
    Asghar S; Asghar S; Mahmood T; Bukhari SMH; Mumtaz MH; Rasheed A
    Cureus; 2023 Aug; 15(8):e43190. PubMed ID: 37692611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study.
    Chu L; Fuller M; Jervis K; Ciaccia A; Abitbol A
    Clin Ther; 2021 Sep; 43(9):1558-1573. PubMed ID: 34426012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.
    Tong L; Adler S
    Postgrad Med; 2018 May; 130(4):381-393. PubMed ID: 29667921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.
    Penno G; Garofolo M; Del Prato S
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):361-73. PubMed ID: 27105869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.
    Sonmez A; Tasci I; Demirci I; Haymana C; Barcin C; Aydin H; Cetinkalp S; Ozturk FY; Gul K; Sabuncu T; Satman I; Bayram F;
    Diabetes Ther; 2020 May; 11(5):1045-1059. PubMed ID: 32088879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease.
    Rhee JJ; Han J; Montez-Rath ME; Kim SH; Cullen MR; Stafford RS; Winkelmayer WC; Chertow GM
    J Diabetes Complications; 2019 Nov; 33(11):107423. PubMed ID: 31537413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.
    Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D
    Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa.
    Mhundwa W; Joubert G; Mofokeng TR
    S Afr Fam Pract (2004); 2023 May; 65(1):e1-e6. PubMed ID: 37265141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose adjustment of metformin and dipeptidyl-peptidase IV inhibitors in diabetic patients with renal dysfunction.
    Melzer-Cohen C; Karasik A; Leuschner PJ; Azuri J; Shalev V; Chodick G
    Curr Med Res Opin; 2018 Oct; 34(10):1849-1854. PubMed ID: 29611727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipeptidyl Peptidase-4 Inhibitors in Chronic Kidney Disease: A Systematic Review of Randomized Clinical Trials.
    Walker SR; Komenda P; Khojah S; Al-Tuwaijri W; MacDonald K; Hiebert B; Tangri N; Nadurak SWD; Ferguson TW; Rigatto C; Tangri N
    Nephron; 2017; 136(2):85-94. PubMed ID: 28178698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.